These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9288073)

  • 1. Antioxidants and ischaemic heart disease.
    Shahar E
    Lancet; 1997 Aug; 350(9078):667; author reply 668. PubMed ID: 9288073
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction.
    Rapola JM; Virtamo J; Ripatti S; Huttunen JK; Albanes D; Taylor PR; Heinonen OP
    Lancet; 1997 Jun; 349(9067):1715-20. PubMed ID: 9193380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidants and ischaemic heart disease.
    Violi F; Iuliano L
    Lancet; 1997 Aug; 350(9078):667-8. PubMed ID: 9288075
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vitamin E for prevention of arteriosclerosis, coronary heart disease and cancer. Antioxidants--what is their value? Minerals, Vitamins & Co. Series, 6: Beta-carotene, vitamin C and E].
    Pannewig K
    Fortschr Med; 1998 Oct; 116(29):61-2. PubMed ID: 9846478
    [No Abstract]   [Full Text] [Related]  

  • 5. AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: A statement for healthcare professionals from the American Heart Association.
    Tribble DL
    Circulation; 1999 Feb; 99(4):591-5. PubMed ID: 9927409
    [No Abstract]   [Full Text] [Related]  

  • 6. [Nutrition and health--unclear association between intake of vitamin E and the risk of coronary heart disease].
    Buijsse B; Feskens EJ; Kromhout D
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2007-11. PubMed ID: 14587142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidants and ischaemic heart disease.
    Leo MA; Lieber CS
    Lancet; 1997 Aug; 350(9078):667; author reply 668. PubMed ID: 9288074
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationships between serum levels of autoantibodies against oxidized low density lipoproteins, lipid-soluble antioxidants and apolipoprotein B in patients with coronary heart disease.
    Bakalova RA; Hadzhimitova V; Ribarov S
    Gen Physiol Biophys; 2000 Mar; 19(1):103-13. PubMed ID: 10930142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies.
    Ye Z; Song H
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):26-34. PubMed ID: 18277182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Carotene and alpha-tocopherol inhibit the development of atherosclerotic lesions in hypercholesterolemic rabbits.
    Sun J; Giraud DW; Moxley RA; Driskell JA
    Int J Vitam Nutr Res; 1997; 67(3):155-63. PubMed ID: 9202975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on vitamin supplements for the prevention of coronary disease and stroke.
    Pearce KA; Boosalis MG; Yeager B
    Am Fam Physician; 2000 Sep; 62(6):1359-66. PubMed ID: 11011864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of alpha-tocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study.
    Törnwall ME; Virtamo J; Korhonen PA; Virtanen MJ; Taylor PR; Albanes D; Huttunen JK
    Eur Heart J; 2004 Jul; 25(13):1171-8. PubMed ID: 15231376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin E and coronary heart disease--why the lack of effect in large clinical trials?].
    Andersen JR
    Tidsskr Nor Laegeforen; 2001 Jun; 121(16):1932-6. PubMed ID: 11488186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oxidant therapy for ischaemic heart disease: where do we stand?
    Stephens N
    Lancet; 1997 Jun; 349(9067):1710-1. PubMed ID: 9193375
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitamins and coronary heart disease: where do we stand?
    Mendis S
    Ceylon Med J; 1998 Jun; 43(2):68-73. PubMed ID: 9704544
    [No Abstract]   [Full Text] [Related]  

  • 16. Antioxidants and prevention of cognitive decline: does duration of use matter?
    Yaffe K
    Arch Intern Med; 2007 Nov; 167(20):2167-8. PubMed ID: 17998489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can vitamin E prevent development of coronary heart disease?].
    Nguyen KN; Landmark K
    Tidsskr Nor Laegeforen; 1996 Mar; 116(9):1109-13. PubMed ID: 8658483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of antioxidant supplements in coronary heart disease.
    Kritharides L; Stocker R
    Atherosclerosis; 2002 Oct; 164(2):211-9. PubMed ID: 12204790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis.
    Li FJ; Shen L; Ji HF
    J Alzheimers Dis; 2012; 31(2):253-8. PubMed ID: 22543848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vitamin E in the prevention of coronary events and stroke. Meta-analysis of randomized controlled trials.
    Alkhenizan AH; Al-Omran MA
    Saudi Med J; 2004 Dec; 25(12):1808-14. PubMed ID: 15711645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.